Contact-inhibition ubiquitously exists in non-transformed normal cells when neighboring cells are in contact. This phenomenon explains poor regenerative capacity of in vivo human corneal endothelial cells during aging, injury, and surgery. This study demonstrated that the conventional approach of expanding human corneal endothelial cells by disrupting contact inhibition with EDTA followed by bFGF actually activated the canonical Wnt signaling and lost the normal phenotype to endothelial-mesenchymal transition, especially if TGF-β1 was added. In contrast, p120 siRNA also uniquely promoted proliferation of the endothelial cells by activating p120-catenin trafficking to the nucleus, thus relieving repression by nuclear Kaiso. This nuclear p120-catenin/Kaiso signaling is associated with activation of RhoA-ROCK signaling, destabilization of microtubules, and inhibition of Hippo signaling, but not with activation of Wnt/β-catenin signaling. Consequently, proliferating human corneal endothelial cells maintained a hexagonal shape with junctional expression of N-cadherin, ZO-1, and Na-K-ATPase.
Introduction
The corneal endothelium forms a single monolayer of hexagonal cells lining on the basement membrane-containing Descemet membrane of the posterior cornea and facing the TGF-β2-containing aqueous humor (Chen et al., 1999) . Through expression of ZO-1, a tight junction component, and Na-K-ATPase to exert barrier and pump functions, respectively, human corneal endothelial cells (HCEC) play a pivotal role in regulating corneal stromal hydration and hence transparency (reviewed in (Bonanno, 2003) ). Unlike other species such as murine, rabbit, and bovine, HCEC are notorious for their limited proliferative capacity in vivo after injury, aging, and surgery (Laing et al., 1984 ).
HCEC's limited proliferative capacity is caused by the mitotic arrest at the G1 phase of the cell cycle (reviewed in (Joyce, 2005) ). A similar mitotic block is also reported in cat (Petroll et al., 1998) and human (Senoo et al., 2000) corneal explants, as well as confluent rat corneal endothelial cultures (Joyce et al., 2002) because of "contact inhibition." The conventional approach of expanding HCEC in vitro is to disrupt cell junctions by EDTA followed by culturing them in a medium supplemented with mitogens, such as bFGF (Engelmann et al., 1988) . Nevertheless, such a culturing method casts the concern of activating "endothelial-mesenchymal transformation" (EMT), a pathologic process that may generate "retrocorneal fibrous membrane," leading to corneal blindness (reviewed in (Lee and Kay, 2006) ).
Intercellular junctions include gap junction, adherent junction (AJ), and tight junction, among which AJ plays an important role in controlling many cellular behaviors, including proliferation, differentiation, and survival (reviewed in (Perez-Moreno et al.,
2003)).
Although not fully elucidated, the mechanism governing contact inhibitionmediated mitotic block likely involves signaling transmitted from AJ to the nucleus (reviewed in (Matter et al., 2005 ; Perez-Moreno et al., 2003)). Conventionally, two signaling pathways could be elicted via β-catenin and p120-catenin (hereafter p120), respectively, when the AJ junction is disrupted. The former is known as the canonical Wnt pathway, in which β-catenin, if accumulated in the cytoplasm without prompt degradation via binding with β-TrCP, can be translocated into the nucleus, where it acts as a transcriptional coactivator through binding with T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors (reviewed in (Nelson and Nusse, 2004) ). The
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latter may trigger the p120/Kaiso pathway, in which nuclear translocated p120 relieves the repressor activity of Kaiso, a member of BTB/POZ-ZF transcription factor family ( (Kelly et al., 2004) , also reviewed in (Daniel, 2007) ). It To resolve these questions, we have isolated HCEC by collagenase instead of trypsin/EDTA or dispase to avoid disrupting intercellular junctions and cell matrix (basement membrane) interaction (Li et al., 2007) , and we have demonstrated that such cultured HCEC monolayers also exhibit contact inhibition when AJ matures to an in vivo pattern (Zhu et al., 2008) . Herein, we demonstrate that the aforementioned mitotic block, unlocked by EDTA with bFGF, is mediated by the canonical Wnt signaling and induces EMT, especially if TGF-β1 is added. In contrast, the mitotic block unlocked by p120 siRNA is causatively related to activation of p120 trafficking to the nucleus, relief of repression by nuclear Kaiso, activation of RhoA-ROCK signaling, inhibition of Hippo signaling, but not activation of β-catenin/Wnt signaling. Consequently, HCEC retain a normal phenotype without EMT despite addition of bFGF and TGF-β1. These results highlight the feasibility of deploying a novel strategy of tissue engineering of HCEC and other similar tissues by selective activation of p120/Kaiso signaling without the use of single cells by disrupting adherent junction.

Results
Mitotic block unlocked by EDTA-bFGF induces EMT, especially if TGF-β1 is added.
As a first step of exploring the signaling involved in controlling contact inhibition, we isolated HCEC by collagenase, but not trypsin or dispase, to retain cell junctions and cell-basement membrane interaction (Li et al., 2007) , and we demonstrated that in vitro HCEC monolayers exhibit contact inhibition when their AJ matures to an in vivo pattern (Zhu et al., 2008) . Similar contact inhibition can be unlocked by scraping, followed by culturing with bFGF or bFGF plus TGFβ in cat corneal buttons (Petroll et al., 1998) , or by disrupting cell junctions with EDTA in human corneal buttons pre-incubated in a medium with EGF and FGF (Senoo et al., 2000) . Exposure of mitotically quiescent HCEC monolayers to 5 mM EDTA for 1 h alone led to notable disruption of intercellular junction (Fig. 1A) . Without bFGF, cells restored their pre-treatment monolayer morphology in two days (not shown). However, immediately following EDTA treatment, when 20 ng/ml bFGF was added for 2 days, 10 ng/ml TGFβ1 was added for 3 days, or 20 ng/ml bFGF was added for 2 days followed by 10 ng/ml TGFβ1 for 3 days, HCEC turned into fibroblastic-like cells with relocation of N-cadherin from the cell junction to the cytoplasm (Fig. 1A) . Nuclear BrdU staining was negative when the cells were treated with PBS or EDTA alone (Fig. 1A) . However, the BrdU labeling index was promoted to ~19% by bFGF, but not TGFβ1 alone or bFGF plus TGFβ1 (Fig. 1A) , suggesting that the mitotic block could only be unlocked by bFGF when EDTA was used to disrupt cell junctions. Immunostaining to S100A4, an early marker of epithelial mesenchymal transition (Basile et al., 2011) , showed the S100A4 staining was negative in cells with or without EDTA treatment, but became positive in the cytoplasm and the nucleus after addition of bFGF or TGF-β1, and exclusively in the nucleus when both bFGF and TGFβ1 were added (Fig. 1A) . In addition, α-smooth muscle actin (α-SMA), a marker indicative of myofibroblast differentiation (Gabbiani, 2003) , became strongly positive only when TGF-β was added (Fig. 1A) . The EMT caused by EDTA-bFGF was accompanied by the loss of the normal HCEC phenotype because junctional staining of N-cadherin, ZO-1, and Na-K-ATPase turned into the cytoplasmic staining pattern (Fig.   1B) . Collectively, these results indicated that the contact inhibition unlocked by EDTAJournal of Cell Science Accepted manuscript bFGF initiated EMT with proliferation, while full-blown EMT without proliferation developed after additional TGF-β1.
Mitotic block unlocked by EDTA-bFGF is causatively mediated by the canonical Wnt signaling.
Because S100A4 is a transcriptional target of the canonical β-catenin/Wnt signaling (Sack and Stein, 2009), we wondered whether the Wnt signaling was activated to unlock the mitotic block of HCEC monolayers. Compared to the PBS control, EDTA alone did not change the expression of β-catenin and LEF1 mRNAs and proteins (not shown). However, EDTA-bFGF elevated 2-and 3-fold of the level of β-catenin and LEF1 mRNAs, respectively ( Fig. 2A, n=3) . Immunostaining confirmed the junctional localization of β-catenin and the absence of nuclear LEF1 in cells treated with PBS ( Fig.   2B ) or EDTA alone (not shown). In contrast, EDTA-bFGF reduced β-catenin in the cell junction, increased its accumulation in the cytoplasm and the nucleus, and notably enhanced the LEF1 nuclear staining (Fig. 2B) . The aforementioned change of immunostaining was confirmed by semi-quantitative protein dot blotting using membranous, cytosolic, and nuclear extracts. Based on the loading control, i.e., CN43, α-tubulin, and histone, respectively, the β-catenin protein level was decreased by 5-fold in the membranous compartment, but increased 3-and 6-fold in cytosolic and nuclear compartments, respectively. At the same time, EDTA-bFGF increased 3-fold of the LEF1 level in the nuclear compartment (Fig. 2C) . These results collectively supported the notion that the mitotic block unlocked by EDTA-bFGF correlated with activation of the canonical Wnt signaling. Such an activation of Wnt signaling was not observed when TGF-β1 was added (not shown).
To confirm that the above correlation was causative, we transfected HCEC monolayers with a plasmid containing TCF/LEF promoter construct and simultaneously treated the cells with XAV939, an inhibitor of β-catenin-mediated signaling through inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2 (Huang et al., 2009 ). As expected, the promoter activity was low in PBS or EDTA treated groups alone, but was elevated 6-fold in EDTA-bFGF treated group (Fig. 2D) . Such an elevated Journal of Cell Science Accepted manuscript promoter activity was completely suppressed by XAV939 (Fig. 2D) . As a result, the BrdU labeling reverted to the baseline quiescence, while β-catenin remained in the junction and S-100A4 was negative without EMT (Fig. 2E) . In fact, the junctional staining of N-cadherin, ZO-1, and Na-K-ATPase was retained (Fig. 2E) . In addition, the notion that activation of Wnt signaling induced proliferation and EMT was further confirmed by overexpression of stable S33Y β-catenin in contact-inhibited HCEC monolayers treated with EDTA, but without bFGF. In such cases, Wnt signaling was activated ( Fig. 2G) while nuclear BrdU labeling, β-catenin, LEF-1 and S100A4 as well as cytoplasmic α-SMA and N-cadherin were significantly increased (Fig. 2F) . In fact, overexpression of stable S33Y β-catenin also rescued proliferation and EMT inhibited by XAV939 (not shown).
HCEC mitotic block is uniquely unlocked by p120 siRNAwithout EMT.
Because disruption of AJ by EDTA induced EMT by activating the Wnt signaling ( Fig. 1 and 2 ), we took a different approach by perturbing intercellular junction components with siRNAs to downregulate p120, β-catenin, N-cadherin, or ZO-1. The knockdown efficiency of these siRNAs was verified by both real-time PCR and Western blotting (Supplemental Fig. 1A and 1B) . To our surprise, the BrdU labeling index was also promoted to ~18% in HCEC monolayers when treated with p120 siRNA, but not with siRNA of β-catenin, N-cadherin, or ZO-1 (Fig. 3A) . Unlike EDTA treatment (Fig.   1A ), addition of bFGF did not further increase BrdU labeling that was already promoted by p120 siRNA (Fig. 3B) . The above result was confirmed by using 3 other independent p120 siRNAs with target sequences 5'GCCAGAGGTGGTTCGGATA3' (Wildenberg et importantly, HCEC treated with p120 siRNA remained hexagonal and did not express cytoplasmic or nuclear S100A4 and cytoplasmic α-SMA, even with additional bFGF and TGFβ (Fig. 3B) . These results collectively indicated that the mitotic block unlocked by p120 siRNA retained the normal HCEC phenotype without inducing EMT. In contrast, p120 siRNA decreased HCEC proliferation by 7-fold when the cells were dissociated into single cells by EDTA/trypsin (Fig. 3C ). ). In contrast, nuclear p120 staining was apparent when cells were fixed by 25% acetic acid plus 75% methanol (Supplemental Fig. 2 ). To determine whether nuclear accumulation of p120 triggered by p120 siRNA might cause the release of nuclear Kaiso's transcriptional repression as suggested (reviewed in (Daniel, 2007) ), we first examined the expression of p120 and Kaiso transcripts by real-time PCR. Compared to the control treated with scRNA, HCEC treated with p120 siRNA expressed 20-and 3-fold decrease of p120 and Kaiso transcripts, respectively (Fig. 4A) . As a contrast, p120 siRNA did not alter the levels of β-catenin and LEF1 transcripts (Fig. 4A) . Compared to scRNA, p120 siRNA markedly reduced p120 staining in the cell junction, but increased that in the nucleus, where it was colocalized with increased BrdU nuclear staining ( Fig.   4B ). At the same time, nuclear staining of Kaiso was markedly reduced (Fig. 4B) . As a comparison, the junctional β-catenin staining and the nuclear LEF1 staining were not changed by p120 siRNA when compared to the controls (Fig. 4B) . The aforementioned immunostaining differences were confirmed by semi-quantitation of these protein levels by dot blotting using membranous, cytosolic, and nuclear lysates. p120 siRNA indeed reduced 4-fold of the membranous p120 level, but increased 3-fold of the nuclear p120 level, while reduced 4-fold of the nuclear Kaiso level (Fig. 4C) . As a comparison, the dot blotting showed that p120 siRNA did not change β-catenin and LEF1 levels in these 3 compartments (Fig. 4C ). EDTA-bFGF, which activated the Wnt signaling (Fig. 2) , neither affected junctional p120 and nuclear Kaiso staining, (Fig. 4D ) nor reduced p120
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and Kaiso protein levels in these 3 compartments (Fig. 4E) . Collectively, these results
showed that the mitotic block unlocked by p120 siRNA led to nuclear translocation of p120, which correlated well with the decrease of nuclear Kaiso, and that such an unlocking effect was not accompanied by changes of cytolocalization of β-catenin and LEF1 and the TCF/LEF promoter activity (not shown). p120 nuclear translocation is directly responsible for releasing nuclear Kaiso to unlock HCEC mitotic block.
Although p120 siRNA led to nuclear translocation of p120 and nuclear release of Kaiso ( Fig. 4B and 4C ), it also reduced the level of Kaiso transcript by 70% (Fig. 4A ). To discern whether Kaiso nuclear release was directly influenced by p120 nuclear translocation or indirectly via downregulation of Kaiso transcription, we tested the effect of Kaiso siRNA knockdown, of which the efficiency was confirmed by reducing 85% of Kaiso transcripts (Supplemental Fig. 1 ). When HCEC monolayers were treated with Kaiso siRNA alone, the protein dot assay showed that nuclear Kaiso level ( Fig. 5A ) and Kaiso staining (Fig, 5B) were not altered when compared to the control treated with scRNA. Double immunostaining confirmed that junctional staining of p120 was not reduced, and nuclear BrdU labeling was not promoted (Fig. 5B ). These results indicated that reduction of Kaiso transcription alone by Kaiso siRNA knockdown could not alter the nuclear Kaiso level and hence was not sufficient to unlock the mitotic block. Nonetheless, the nuclear Kaiso level was reduced 4-fold when cells were treated with p120 siRNA alone, and reduced 6-fold when cells were treated with both p120 and Kaiso siRNAs (Fig. 5A) . Consequently, the BrdU labeling index was increased 18% by treatment of p120 siRNA alone, and increased 26% by treatment of both p120 and Kaiso siRNAs (Fig. 5B) . These results further suggested that the release of nuclear Kaiso was crucial for unlocking the mitotic block of HCEC monolayers, and such an effect could not be achieved by Kaiso siRNA alone, unless p120 siRNA was instituted to trigger p120 nuclear translocation.
To further prove that nuclear translocation of p120 was crucial for Kaiso nuclear release to unlock the mitotic block, we examined the effect of nocodazole or taxol (Roczniak-Ferguson and Reynolds, 2003), which is known to depolymerize or stabilize the microtubule network, respectively, to affect the cytoplasmic p120 pool, thus indirectly affecting p120 nuclear translocation (Yanagisawa et al., 2004) . Compared to the control treated with scRNA, addition of nocodazole increased the nuclear p120 level from 3-to 5-fold when HCEC monolayers were treated with p120 siRNA (Fig. 5C ). In contrast, addition of taxol reduced the p120 nuclear level to that of the control ( Fig. 5C and 5E). Consequently, the nuclear Kaiso level was decreased 2-fold by nocodazole, but increased by taxol to the level of the scRNA control (Fig. 5D ). The aforementioned changes of nuclear p120 and Kaiso levels were also reflected by the extent of nuclear p120 and Kaiso staining (Fig. 5E) . Consequently, the BrdU labeling index was enhanced from 18% to 24% by nocodazole, but decreased to that of control level by taxol (Fig. 5E ).
Collectively, these results indicated that the extent of p120 nuclear translocalization played a dominant role in reducing the nuclear level of Kaiso to unlock the mitotic block of HCEC monolayers. we wondered whether RhoA was activated by p120 siRNA in a similar manner to nocodazole, resulting in proliferation mediated by p120 nuclear translocation. Indeed we noted that the level of active RhoA was increased 3-fold by p120 siRNAand 4-fold with additional nocodazole (Fig. 6A ). In contrast, the level of active RhoA promoted by p120 siRNA or p120 siRNA and nocodazole was suppressed by Taxol to the baseline level.
Under this scenario, nuclear p120 staining and BrdU labeling promoted by p120 siRNA and nocodazole was abolished by taxol, CT-04 (a RhoA inhibitor), or Y27632 (a ROCK inhibitor) (Fig. 6B ). These results suggested that activation of RhoA-ROCK signaling was correlated with destabilization of microtubules and p120 nuclear translocation and proliferation.
Hippo signaling is inhibited by p120 siRNA, but not EDTA-bFGF
The Hippo pathway is a key protein kinase cascade involved in regulating in vivo organ size and in vitro contact inhibition by governing cell proliferation and apoptosis (Zeng and Hong, 2008). To determine whether Hippo signaling was also affected, we examined and quantified the cytolocalization of phosphorylated and non-phosphorylated YAP and TAZ, which are the prime mediators of the Hippo pathway (Zhao et al., 2010).
Both immunostaining and Western blotting showed that non-phosphorylated YAP and TAZ were accumulated in the nucleus after treatment of p120 siRNA, while cytoplasmic phosphorylated YAP and TAZ was dramatically reduced in the cytoplasm as compared to the control treated with scRNA (Fig 7A and 7B) . As a comparison, EDTA-bFGF failed to elicit any change (Fig 7C and 7D) . Because the pYAP (S127) antibody detected both pYAP and pTAZ (Habbig et These results indicated that p120 siRNA, but not EDTA-bFGF, inhibited Hippo signaling by decreasing cytoplasmic pTAZ and pYAP, but increasing nuclear TAZ and YAP, further suggesting that selective activation of p120/Kaiso signaling also uniquely inhibited the Hippo signaling.
Prolonged treatment of p120 siRNA followed by withdrawal leads to further expansion of HCEC monolayers without EMT
The above experiments based on a short pulse of 100 nM p120 siRNA knockdown for 48 h was capable of unlocking the HCEC mitotic block without inducing EMT by selective activation of p120/Kaiso and inhibition of Hippo signaling. It remained unclear whether proliferation could be sustained without EMT by prolonging treatment of p120 siRNA. A total of 18 HCEC monolayers derived from three separate donors with ages of 55 (Fig. 8A, d1 and D1), 58 (d2 and D1), and 76 (d3 and D3) were treated with 40 nM of either p120 siRNA or scRNA (n=3 for each for each donor) weekly from Day 14 for two weeks followed by withdrawal on Day 28 for 10 days. The HCEC monolayers treated with scRNA virtually turned quiescent after 18 days of culturing (Fig 8A, d1-d3 ).
In contrast, the HCEC monolayers treated with p120 siRNA continued growth during the entire 27 days of culturing (Fig 8A, D1-D3 ). At Day 27, the monolayer size of the control treated with scRNA rapidly declined to an average of 1.7 ± 0.4 mm 2 (n=9), while that of the p120 siRNA-treated counterpart continued to expand to 3.7 ± 0.7 mm 2 (n=9).
To ensure that the aforementioned change of monolayer size was resulted from cell proliferation but not cell enlargement, we measured the HCEC cell density. HCEC of the Descemet membrane stripped from the donor peripheral cornea showed a characteristic in vivo hexagonal pattern with the average density of 2241 ± 104 /mm 2 ( Fig 8B, a, n=5 donors) . HCEC monolayers cultured in SHEM up to Day 14 also maintained a similar hexagonal pattern with a significant increase of cell density to 2548 ± 93 /mm 2 ( Fig 8B, b, n=5 Immunostaining confirmed that the normal HCEC phenotype, judged by junctional staining of p120, N-cadherin, ZO-1 and Na-K-ATPase as well as by perimembranous staining of F-actin, was maintained in the control treated with scRNA ( Fig   8C , the top row). Prolonged treatment of p120 siRNA for two weeks resulted in significant reduction of p120 junctional staining and an increase of p120 nuclear staining Ten days after withdrawal of p120 siRNA, the immunostaining pattern was completely reverted to that of the control for all these 5 markers ( Fig 8C, the bottom row) . These results collectively indicated that prolonged treatment of p120 siRNA further expanded HCEC monolayer sizes while maintaining the normal hexagonal morphology at the same cell density without EMT (not shown). Following withdrawal of p120 siRNA, the normal HCEC phenotype was completely restored in 10 days. In cultured HCEC monolayers, contact inhibition disrupted by EDTA did not unlock the mitotic block even in EGF-containing SHEM until bFGF was added (Fig. 1) . By that time HCEC had lost their normal phenotype expressing the junctional staining of N-cadherin, ZO-1, and Na-K-ATPase, changed to a slender shape, and begun to express cytoplasmic and nuclear staining of S100A4 (Fig. 1) , a marker of epithelial-mesenchymal transition We further demonstrated that the mitotic block of HCEC monolayers unlocked by EDTA-bFGF was caused by selective activation of the canonical Wnt signaling. EDTAbFGF led to nuclear translocation of β-catenin, a significant increase of nuclear β-catenin and LEF1 protein levels, and a significant increase of the TCF/LEF promoter activity (Fig. 2) . Furthermore, addition of a specific Wnt inhibitor XAV939 (Huang et al., 2009) abolished BrdU labeling, cytoplasmic and nuclear staining of S100A4, cytoplasmic α-SMA, and retained the junctional staining of N-cadherin, ZO-1 and Na-K-ATPase in EDTA-bFGF treated HCEC even if TGFβ1 was added (Fig. 2) . Such a change can be completely reverted by overexpression of stable S33Y β-catenin (Fig. 2) . To our best Realizing the aforementioned drawback of activating the Wnt signaling by EDTA-bFGF in HCEC, herein we discovered that contact inhibition of HCEC monolayers could also be unlocked by p120 siRNA. Similar to EDTA-bFGF treatment, a high BrdU labeling index was uniquely promoted by knockdown of p120, but not β-catenin, N-cadherin, or ZO-1 (Fig. 3) . Unlike EDTA-bFGF, p120 siRNA, which downregulated p120 transcript and protein levels, actually perturbed neither transcription and junctional staining of β-catenin and N-cadherin (not shown) nor transcription and nuclear protein level of LEF1 (Fig. 4) . The above finding was surprising, given the fact that p120 is known to play a key role in stabilizing cadherins at the membrane when AJ But none of these studies showed increased proliferation after treatment of p120 siRNA.
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We attributed such a discrepancy to their use of EDTA/trypsin dissociated cells, because p120 siRNA actually reduced cell proliferation when HCEC were dissociated into single cells by EDTA/trypsin (Fig. 3) . These data highlights a unqiue role of p120 in govering contact inhibition in post-confluent cultures.
The mitotic block of contact-inhibited HCEC monolayers unlocked by p120 . However, the importance of nuclear p120 in eliciting downstream signaling has not been appropriately addressed, presumably because of the controvery surrounding nuclear p120 staining when cells were fixed by paraformaldehyde. We discovered that p120 nuclear staining was apparent in HCEC monolayers only when fixed by methanol and acetic acid (Supplemental Fig. 2 ). Accompanied by downregulation of p120 transcript and protein, p120 siRNA dramatically shifts p120 cytolocalization from the junction/membrane to the nucleus, where it was colocalized with BrdU-labeling and correlated with the release of nuclear Kaiso (Fig. 4) . Consistent with what has been noted in a number of cell lines (Roczniak-Ferguson and Reynolds, 2003), the extent of nuclear p120 level elicited by p120 siRNA could be augmented by nocodazole, a microtube-disrupting agent, but diminished by taxol, a microtube-stablizing agent (Fig 5) , confirming that p120 shuttling from the cytoplasm to the nucleus could be facilitated by perturbing the microtubular network. Consequently, the nuclear p120 level manipulated by nocodazole and taxol, respectively, was inversely correlated with the nuclear level of Kaiso, strongly suggesting that the former dictates the latter. Similar to porcine pulmonary artery endothelial cells (Zhang et al., 2010), p120 knockdown in HCEC monolayers also downregulated Kasio transcription (Fig. 4) . Herein, for the first time, we showed that Kaiso siRNA per se, which downregulated Kaiso transcript and protein (Supplemental Fig. 1 ), was incapable of reducing the nuclear Kaiso level unless nuclear p120 was elicited (Fig. 5) . Such a finding suggests that the homeostasis of nuclear Kaiso is tightly regulated and cannot be influenced by its own transcription and translation in a short term. Nonetheless, Kaiso siRNA was synergistic with p120 siRNA in further lowering the nuclear Kaiso level ( To rule out the concern of carcinogenesis based on the finding that enhanced nuclear p120 levels are noted in several tumor cell lines (reviewed in (Daniel, 2007) ), we prolonged p120 siRNA treatment for two weeks. Our results showed a wider spread of BrdU labeling from the periphery to the center of HCEC monolayers (not shown).
Consequently, the mitotically arrested HCEC monolayers continued to expand its size from an average of 1.6 mm 2 to 3.7 mm 2 while maintaining the same cell density.
Importantly, prolonged p120 knockdown did not alter the characteristic hexagonal shape and junctional expression of N-cadherin, ZO-1, and Na-K-ATPase, suggesting their barrier and pump functions were preserved (Fig 8) . Both p120 nuclear translocation and dissolution of peri-membranous F-actin cables were transient and reversed to the normal pattern following the withdrawal of p120 siRNA. Hence, it is plausible to deploy this novel strategy of selectively activating the p120/Kaiso signaling to expand HCEC monolayers using the the donor scleral rim left after corneal transplantation. This new engineering strategy will not only obviate the use of enzymatic digestion to produce single HCEC but also avoid the loss of their normal phenotype to EMT during ex vivo expansion of HCEC. If accomplished, this new technology will not only help solve the global shortage of human donor corneas but also facilitate the current popular trend of transplanting only the corneal endothelium in procedures collectively termed "endothelial keratoplasty" (reviewed in (Terry, 2006) ). Our on-going experiments showed that this technology can also be applied to achieve the same goal in the human retinal pigment epithelium. 
Materials and Methods
Reagents
RhoA Activity Assay
The assay of Rho activation was performed in 10-50 μg of protein of cell lysates using RhoA Activation Assay Biochem Kit (Cytoskeleton) to pull down the GTP-bound form of RhoA by a GST fusion protein containing rhotekin (7-89 residues) and RBD protein using brightly colored glutathione affinity beads. The amount of activated RhoA pulled down was quantitatively determined by Western blot using anti-RhoA antibody.
Dot or Western Protein Blotting
Cell lysates were prepared in RIPA buffer and electrophoresized on 4-15 % (w/v) gradient acrylamide ready gels under denaturing and reducing conditions for Western blotting. To prepare protein extracts from the membrane, the cytosol, and the nucleus, we followed Qproteome Cell Compartment protocol (Qiagen). Briefly, cells were first added with Extraction Buffer CE1, which selectively disrupts, but without solubilizing, the plasma membrane, followed by centrifugation at 100 x g for 10 min to pellet plasma membranes and compartmentalized organelles, such as nuclei, mitochondria, and the endoplasmic reticulum. The pellet was then resuspended in Extraction Buffer CE2, which solubilizes the plasma membrane as well as all organelle membranes except the nuclear membrane, followed by centrifugation at 6000 x g for 10 min to pellet nuclei. The supernatant contains membrane proteins and proteins from the endoplasmic reticulum and mitochondria. Finally, the pellet containing nuclei was solubilized using Extraction Buffer CE3 and pelleted by centrifugation at 6800 x g for 10 min. The protein extracts from the above three compartments were transferred to a nitrocellulose membrane, which was then blocked with 5% (w/v) fat-free milk in TBST (50 mM Tris-HCl, pH 7.5, 150
mM NaCl, 0.05% (v/v) Tween-20), followed by sequential incubation with specific primary antibodies against β-catenin, LEF1, p120, Kaiso, RhoA, and their respective secondary antibodies using connexin (CN) 43, α-tublin, and histone as the loading control for the membranous, cytosolic, and nuclear compartments, respectively.
Immunoreactive proteins were detected with Western Lighting TM Chemiluminesence
Reagent.
Statistics
All summary data were reported as means ± s. decreased by p120 siRNA and further by combined p120 and Kaiso siRNAs (n=3, both * p<0.05), but not by Kaiso siRNA (n=3, p>0.05). In contrast, the nuclear p120 level was not affected by Kaiso siRNA, single or in combination with p120 siRNA (not shown, n=3, p>0.05). (B) Double immunostaining of p120 and BrdU (left) showed that BrdU labeling (red) correlated with nuclear p120 staining (green) was promoted by p120 siRNA but not Kaiso siRNA. A synergistic effect was noted by combined treatment with both p120 and
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Kaiso siRNAs (n=3, all * p<0.05). (C) Dot blotting showed the nuclear Kaiso protein level decreased by p120 siRNA was further decreased by nocodazole, but was increased by taxol to that of the control level (n=3, * p<0.05). (D) Nuclear dot blotting showed the nuclear p120 protein level promoted by p120 siRNA was further enhanced by nocodazole, but was decreased by taxol (n=3, * p<0.05). (E) The extent of nuclear p120 and BrdU labeling was negatively correlated with nuclear Kaiso levels, which was decreased by nocodazole but increased by taxol (n=3, * p<0.05). All Bar=100 μM. Immunostaining (A) showed that p120 siRNA led to nuclear accumulation of nonphosphorylated TAZ and YAP and cytoplasmic deletion of phosphorylated TAZ and YAP when compared to that of scRNA. Because the same antibody detects both pYAP and pTAZ, Western instead of dot blotting (B) was used to confirm that both pTAZ and pYAP bands were decreased in the cytoplasm, while TAZ and YAP (detected by different antibodies) were increased in the nuclear extract. In contrast, immunostaining (C) and Western blotting (D) showed that EDTA-bFGF failed to elicit such a change. ± 113 /mm 2 on Day 38 (i.e., 10 days after withdrawal, f, n=5, p>0.05). (C) Prolonged p120 siRNA treatment resulted in nuclear translocation of p120 and dissolution of F-actin without disturbing the junctional staining pattern of N-cadherin, ZO-1, and Na-K-ATPase.
Ten days after withdrawal of p120 siRNA, the staining pattern of p120 and F-actin reverted to the normal pattern while that of the rest remained unchanged. All Bar=100 μM. 
